INS and Hypoglycemia: Importantly, it also minimizes the so-called “shoulder effect,” a pharmacodynamic phenomenon observed with premixed insulins in which overlap between intermediate-acting and rapid-acting components leads to a prolonged insulin peak and increases the risk of postprandial hypoglycemia.